Feverfew.

Magnesium is the standard companion to feverfew in head-comfort formulas because it moderates vascular smooth muscle tone and neuronal excitability. Its route is entirely separate from parthenolide's eicosanoid effect.

Riboflavin feeds flavin cofactors used by mitochondrial electron transport, a different lever from parthenolide's effect on eicosanoid and serotonin signalling. The pairing is established in head-comfort blends for that reason.

Coenzyme Q10 carries electrons within the respiratory chain, addressing cellular energy handling rather than eicosanoid signalling. It is routinely combined with feverfew and riboflavin because the mechanisms do not overlap.

Petasin damps leukotriene formation and calcium entry into smooth muscle, while parthenolide acts mainly on prostaglandin signalling and platelet serotonin release. The two botanicals are combined because they hit different arms of the same response.

Gingerols and parthenolide both damp prostaglandin formation, and ginger adds an effect on gastric motility that feverfew lacks. They are traditionally paired in the same preparations.

Salicin metabolites and parthenolide both reduce thromboxane-driven platelet aggregation. Their effects on normal platelet function add rather than run separately.

Parthenolide inhibits platelet aggregation and serotonin release from platelets, and long-chain omega-3s shift eicosanoid balance the same way. Combined, the effect on normal clotting is additive.

Garlic sulfur compounds lower platelet aggregation by a route separate from parthenolide's eicosanoid effect. Different mechanisms converging on the same endpoint make the combined effect larger.

Ginkgolide B antagonises platelet activating factor while parthenolide acts on thromboxane and platelet serotonin. Both damp platelet aggregation, so the effects add.

Nattokinase acts on fibrin handling while parthenolide acts on platelets, two separate arms of normal clotting. Combining them lowers clotting activity from both sides at once.

High-dose tocopherol reduces platelet adhesion and interferes with vitamin K dependent clotting factor activity. Paired with parthenolide's platelet effect the two add on normal clotting.

Feverfew extracts reduce platelet aggregation and serotonin release from platelet dense granules in laboratory work, and bromelain has its own reported antiplatelet and fibrinolytic activity. Stacked in one formula the two act on the same endpoint by different routes. This is worth flagging rather than promoting, particularly around procedures.

Curcuminoids and feverfew's sesquiterpene lactones both dampen platelet activation in vitro, and both are described as inhibitors of NF-kB signalling in cell systems. The pairing is common in botanical joint and head-comfort blends. The additive direction is on platelet function, which is a flag for anyone already on an agent that affects clotting.

Resveratrol inhibits platelet aggregation in vitro and shares the NF-kB-directed activity described for parthenolide. The combination has not been studied together in people. Read it as mechanistic overlap and as a caution point in stacked polyphenol formulas.

Feverfew leaf carries its own flavonol glycosides alongside parthenolide, and quercetin is chemically part of that same class. Both are described as inhibiting mast cell mediator release in cell models. The overlap is in class chemistry rather than in any combination trial.

Boswellic acids inhibit 5-lipoxygenase and feverfew's lactones act on NF-kB-linked signalling, so the two hit different nodes of the same inflammatory cascade. They appear together in botanical comfort formulas for that reason. The rationale is mechanistic; combination trials are not what supports it.

Both plants are Asteraceae and both carry sesquiterpene lactones, the compound class responsible for contact sensitivity to this family. Someone who reacts to one commonly reacts to the other. Formulating them together concentrates a single class of allergen rather than diversifying it.

Peppermint and feverfew appear together in traditional head-comfort preparations, peppermint usually topically and feverfew orally. The pairing is a use convention with a long history rather than a described pharmacological interaction. Nothing in the chemistry of one changes the other.

Melatonin is combined with feverfew in evening comfort formulas on the reasoning that circadian regularity and the botanical serve the same user. There is no described chemical interaction between them. This is formulation convention, and it is the honest label for it.

Piperine inhibits intestinal and hepatic UGT and CYP3A4 activity, which raises systemic exposure to several co-administered plant compounds. Parthenolide is subject to phase II conjugation, so the mechanism plausibly applies. It has not been measured for parthenolide specifically, and piperine raises exposure to anything else in the formula at the same time.

Grape seed procyanidins are described as reducing platelet aggregation in vitro, the same direction as feverfew extracts. Stacking polyphenol extracts compounds an effect that no single one of them declares. The flag is the point of this row rather than any benefit claim.